The Lancet Infectious Diseases • Vol 25 • No 5
Safety and efficacy of the blood-stage malaria vaccine RH5.1/Matrix-M in Burkina Faso: interim results of a double-blind, randomised, controlled, phase 2b trial in children
December 2024 • Hamtandi Magloire Natama, Jo Salkeld, Anyirékun Fabrice Somé, Seyi Soremekun, S Diallo, Ousmane Traoré, Toussaint Rouamba, Florence Ouédraogo, Edouar…
The European and Developing Countries Clinical Trials Partnership, the UK Medical Research Council, the National Institute for Health and Care Research Oxford Biomedical Research Centre, the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, the US Agency for International Development, and the Wellcome Trust.